InvestorsHub Logo
Followers 33
Posts 2842
Boards Moderated 2
Alias Born 10/24/2015

Re: jondoeuk post# 122

Friday, 06/03/2022 9:02:50 PM

Friday, June 03, 2022 9:02:50 PM

Post# of 265
Ultimately, the company aims to move to iPSC-derived CAR-T cells as well, but its effort in this area is still at an early stage https://www.nature.com/articles/d41587-021-00027-1

They are also working on iPSC-derived CAR-NK cell therapies as well.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRSP News